RAPID HYDROLYSIS INVIVO IN MAN OF FCE-22891, THE ORALLY ABSORBED ESTER OF FCE-22101

被引:5
|
作者
VINCON, G
ALBIN, H
BATTAGLIA, R
MIGNON, A
BENEDETTI, MS
机构
[1] FARMITALIA CARLO ERBA SPA,RES & DEV ERBAMONT GRP,RES & DEV PHARMACOKINET & METAB,I-20159 MILAN,ITALY
[2] HOP PELLEGRIN,F-33076 BORDEAUX,FRANCE
[3] FARMITALIA CARLO ERBA SPA,PARIS DEF,PARIS,FRANCE
关键词
D O I
10.1093/jac/25.3.486
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:486 / 488
页数:3
相关论文
共 11 条
  • [1] TOXICOLOGICAL PROFILE OF FCE-22101 AND ITS ORALLY AVAILABLE ESTER FCE-22891
    BRUGHERA, M
    SCAMPINI, G
    FERRARI, ML
    NAVA, A
    MAZUE, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 129 - 135
  • [2] SYNTHESIS AND ANTIMICROBIAL SPECTRUM OF FCE-22101 AND ITS ORALLY AVAILABLE ESTER FCE-22891
    FRANCESCHI, G
    PERRONE, E
    ALPEGIANI, M
    BEDESCHI, A
    BATTISTINI, C
    ZARINI, F
    DELLABRUNA, C
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 1 - 6
  • [3] SYNTHESES OF [2-C-14]PENEM ANTIBACTERIALS - (FCE-22101 AND FCE-22891)
    FONTANA, E
    ALPEGIANI, M
    PERRONE, E
    VICARIO, GP
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1987, 24 (01): : 41 - 48
  • [4] PHARMACOKINETICS IN HEALTHY-SUBJECTS OF FCE-22101 AND ITS ACETOXYMETHYL ESTER, FCE-22891 - EFFECT OF COADMINISTRATION OF IMIPENEM CILASTATIN ON THE RENAL METABOLISM OF FCE-22101
    NORRBY, SR
    BURMAN, LA
    SASSELLA, D
    CORIGLI, R
    CASSINELLI, G
    FRANCESCHI, G
    DORNBUSCH, K
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (03) : 371 - 383
  • [5] PHARMACOKINETICS AND METABOLISM OF FCE-22101 FOLLOWING ITS ADMINISTRATION AS THE ORAL PRO-DRUG FCE-22891
    LOVERING, AM
    MACGOWAN, AP
    LEWIS, DA
    REEVES, DS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (02) : 179 - 185
  • [6] THE DISPOSITION AND URINARY METABOLISM OF C-14-LABELED FCE-22891, A PRO-DRUG OF FCE-22101, IN ANIMALS
    BATTAGLIA, R
    BENEDETTI, MS
    FRIGERIO, E
    VICARIO, G
    RONCUCCI, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (01) : 133 - 139
  • [7] FCE-22101 AND FCE-22891 - INVITRO ANTIBACTERIAL ACTIVITY AT CONCENTRATIONS SIMULATING HUMAN-PLASMA LEVELS FOLLOWING INTRAVENOUS, INTRAMUSCULAR AND ORAL-ADMINISTRATION
    DELLABRUNA, C
    JABES, D
    ROSSI, R
    YOUNES, G
    CASTELLANI, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 119 - 128
  • [8] SYNTHESIS AND BIOLOGICAL PROPERTIES OF SODIUM (5R,6S,8R)-6-ALPHA-HYDROXYETHYL-2-CARBAMOYLOXYMETHYL-2-PENEM-3-CARBOXYLATE (FCE-22101) AND ITS ORALLY ABSORBED ESTERS FCE-22553 AND FCE-22891
    FRANCESCHI, G
    FOGLIO, M
    ALPEGIANI, M
    BATTISTINI, C
    BEDESCHI, A
    PERRONE, E
    ZARINI, F
    ARCAMONE, F
    DELLABRUNA, C
    SANFILIPPO, A
    JOURNAL OF ANTIBIOTICS, 1983, 36 (07): : 938 - 941
  • [9] PHARMACOKINETICS OF FCE-22101 IN MAN FOLLOWING DIFFERENT MODES OF ADMINISTRATION
    LOVERING, AM
    WHITE, LO
    LEWIS, DA
    MACGOWAN, AP
    ROUTH, KR
    PICKIN, DM
    REEVES, DS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : 179 - 195
  • [10] FCE-22101, A NEW PENEM ANTIBACTERIAL, AND ITS ORAL PRODRUG, FCE-22891 - 28TH INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, LOS-ANGELES, CALIFORNIA, 23-26 OCTOBER 1988 - PREFACE
    REEVES, D
    SPELLER, D
    SPENCER, B
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 : R3 - R3